24-hour Ambulatory Blood Pressure Monitors & Holter ECG Devices
WHAT WE DO
Your ABPM-05 pays for itself! Reimbursable, long-life ambulatory BP monitor with sleep-friendly algorithm and IP22 water-resistance rating. Clinically validated to the BHS and AAMI accuracy criteria. With CE, FDA and CMDR market clearance.
Undiagnosed sleep apnea improves the risk of sleep-related traffic accidents. With apneABP one short test is enough to screen for sleep apnea and hypertension in primary care!
24 hour blood pressure monitor in OEM. Your brand, our quality. Save time and costs with our complex solution!
Professional 7-lead Holter ECG with 5in1 software package, which includes beat-by-beat annotation, event distribution, time and frequency domain HRV and QT dispersion.
Who we are
Meditech is committed to preserving cardiovascular health by manufacturing, developing and marketing 24-hour blood pressure and ECG monitors since 1990. In a world focused on things, we focus first on people.
The Meditech office is closed between 23. December and 01. January. We wish you happy holidays and all the best for the new year!
The latest version of CardioVisions ABPM and ECG management software is available on our website in English, Hungarian, Swedish, Russian, Spanish, Italian, Serbian and in the Slovak language.
For one week only, we are offering 40% off our Holter monitors!
Download Meditech software solutions and user guides after login! Don't you have any account yet? Register now!
Who already work with us
Our partners are our best advertising! Meditech Holters are distributed to and used in physicians' and specialists' offices, hospitals and in international research programs.
Snoring and other sleep disorders may have rather serious consequences, even death.
Is wilderness a necessity? Go to a forest, walk slowly, breathe and heal! Japanese researchers are seeking a new preventive method against lifestyle-related diseases and proposed a new concept called forest bathing or Shinrin-yoku.
Hypertension affects 40% of adults over the age of 25 worldwide, and it represents a major risk factor for cardiovascular disease, chronic kidney disease, and death, but it often remains undiagnosed until complications arise.